Imago BioSciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $42,524,000.
Profit Margin
| 2019 | 0 | -10.90M | |
|---|---|---|---|
| 2020 | 0 | -17.83M | |
| 2021 | 0 | -42.31M |
IMGO Income Statement (2019 – 2021)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
Revenue | |||
Revenue | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 |
Operating exp. | |||
Research and development | 32.26M | 14.89M | 8.23M |
Selling and marketing | 0 | 0 | 0 |
Total operating expenses | 42.52M | 18.07M | 10.65M |
Operating income | -41.99M | -18.07M | -10.65M |
Other income (expenses), net | -314K | 242K | -246K |
Income before tax | -42.30M | -17.83M | -10.90M |
Income tax expense | 2K | 3K | 0 |
Net income | -42.31M | -17.83M | -10.90M |
Earnings per share | |||
Basic EPS | -3.16 | -1.33 | -0.81 |
Diluted EPS | -3.16 | -1.33 | -0.81 |
| Data source |